Video LectureSpotlight on Testing: Imatinib - Therapeutic Drug Monitoring

Originally published on May 17, 2018



Lecture Presenter

Gwendolyn A. McMillin, PhD

Gwendolyn A. McMillin, PhD

Medical Director, Toxicology
ARUP Laboratories
Medical Director, Pharmacogenetics
ARUP Laboratories

Dr. McMillin is a professor of pathology at the University of Utah School of Medicine. She received her PhD in pharmacology and toxicology from the University of Utah and is certified by the American Board of Clinical Chemistry in clinical chemistry and toxicological chemistry. She is a member of ARUP’s R&D Executive Committee, and is actively involved in professional associations such as the International Association of Therapeutic Drug Monitoring and Clinical Chemistry (IATDMCT), the American Association for Clinical Chemistry (AACC), and the College of American Pathologists (CAP). Her primary interests include detection of neonatal drug exposures, pain management, and clinical applications and implementation of pharmacogenomics.



Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories